IDEX Is Maintained at Buy by Stifel
IDEX Is Maintained at Buy by
Stifel Maintains Buy on IDEX, Lowers Price Target to $236
Stifel analyst Nathan Jones maintains IDEX with a Buy and lowers the price target from $265 to $236.
IDEX Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/18/2024 12.71% Stifel $265 → $236 Maintains Buy 04/25/2024 22.27% Baird $260 → $256 Maintains
Stifel Maintains IDEX Corp(IEX.US) With Buy Rating, Cuts Target Price to $236
Stifel analyst Nathan Jones maintains $IDEX Corp(IEX.US)$ with a buy rating, and adjusts the target price from $265 to $236.According to TipRanks data, the analyst has a success rate of 65.6% and a
RBC Cuts Price Target on IDEX to $250 From $285, Keeps Outperform Rating
IDEX (IEX) has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $210 to $277.
Express News | IDEX Corp : RBC Cuts Target Price to $250 From $285
IDEX Corporation's (NYSE:IEX) Share Price Could Signal Some Risk
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 17x, you may consider IDEX Corporation (NYSE:IEX) as a stock to avoid entirely with its 27.1x P/
Peering Into IDEX's Recent Short Interest
IDEX's (NYSE:IEX) short percent of float has risen 17.48% since its last report. The company recently reported that it has 1.12 million shares sold short, which is 1.68% of all regular shares that
TD Cowen Maintains IDEX Corp(IEX.US) With Buy Rating, Maintains Target Price $240
TD Cowen analyst Joseph C Giordano maintains $IDEX Corp(IEX.US)$ with a buy rating, and maintains the target price at $240.According to TipRanks data, the analyst has a success rate of 64.7% and a tot
$100 Invested In This Stock 15 Years Ago Would Be Worth $900 Today
IDEX (NYSE:IEX) has outperformed the market over the past 15 years by 2.28% on an annualized basis producing an average annual return of 15.14%. Currently, IDEX has a market capitalization of $14.77 b
IDEX Corporation to Webcast Second Quarter 2024 Earnings Call
IDEX Corporation (NYSE:IEX) announced today that it has scheduled the broadcast of the company's second quarter earnings conference call over the internet on Thursday, August 1, 2024 at 9:30 a.m. CT. Chief Executive
An Intrinsic Calculation For IDEX Corporation (NYSE:IEX) Suggests It's 40% Undervalued
Key Insights Using the 2 Stage Free Cash Flow to Equity, IDEX fair value estimate is US$334 IDEX is estimated to be 40% undervalued based on current share price of US$201 The US$241 analyst price
XLI: 3M, GE Aerospace Among Industrial Gainers During the Second Quarter; American Airlines Among Laggards
Those Who Invested in IDEX (NYSE:IEX) Five Years Ago Are up 23%
$1000 Invested In IDEX 20 Years Ago Would Be Worth This Much Today
IDEX (NYSE:IEX) has outperformed the market over the past 20 years by 3.57% on an annualized basis producing an average annual return of 11.73%. Currently, IDEX has a market capitalization of $15.48 b
IDEX Corp To Go Ex-Dividend On July 12th, 2024 With 0.69 USD Dividend Per Share
June 20th (Eastern Time) - $IDEX Corp(IEX.US)$ is trading ex-dividend on July 12th, 2024.Shareholders of record on July 12th, 2024 will receive 0.69 USD dividend per share on July 26th, 2024. The ex-d
IDEX Keeps Quarterly Dividend at $0.69 per Share, Payable July 26 to Shareholders of Record July 12
03:03 PM EDT, 06/20/2024 (MT Newswires) -- IDEX Keeps Quarterly Dividend at $0.69 per Share, Payable July 26 to Shareholders of Record July 12 Price: 204.56, Change: +2.21, Percent Change: +1.09
Looking Into IDEX's Recent Short Interest
IDEX's (NYSE:IEX) short percent of float has risen 27.62% since its last report. The company recently reported that it has 892 thousand shares sold short, which is 1.34% of all regular shares that are
These 4 Measures Indicate That IDEX (NYSE:IEX) Is Using Debt Reasonably Well
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' When we think about how risky a company is, we always like
Chemours Names Tony Satterthwaite to Board of Directors
The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced